Christine Dingivan

I’m honored to be the company’s third CEO in its 43-year history. My prior experience included serving as the senior vice president of clinical research and operations for MedImmune-AstraZeneca; chief medical officer of PPD; and both global head of portfolio strategy and innovation and global head of data and digital for Novartis Global Drug Development in Basel, Switzerland. All this widened my clinical research and drug development experience across a range of therapeutic areas and was great preparation for my role at Emmes. I’ve also had the opportunity to serve as an advisor and on the board of directors for several private equity and venture-backed companies in the biopharma, clinical research and genomics fields.